Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) Revenue (2016 - 2025)

Nephros has reported Revenue over the past 16 years, most recently at $4.7 million for Q4 2025.

  • Quarterly results put Revenue at $4.7 million for Q4 2025, up 22.2% from a year ago — trailing twelve months through Dec 2025 was $18.8 million (up 32.67% YoY), and the annual figure for FY2025 was $18.8 million, up 32.67%.
  • Revenue for Q4 2025 was $4.7 million at Nephros, down from $4.8 million in the prior quarter.
  • Over the last five years, Revenue for NEPH hit a ceiling of $4.9 million in Q1 2025 and a floor of $2.2 million in Q1 2022.
  • Median Revenue over the past 5 years was $3.4 million (2023), compared with a mean of $3.4 million.
  • Biggest five-year swings in Revenue: dropped 21.09% in 2022 and later skyrocketed 71.24% in 2023.
  • Nephros' Revenue stood at $2.7 million in 2021, then decreased by 5.71% to $2.6 million in 2022, then rose by 27.21% to $3.3 million in 2023, then grew by 18.93% to $3.9 million in 2024, then rose by 22.2% to $4.7 million in 2025.
  • The last three reported values for Revenue were $4.7 million (Q4 2025), $4.8 million (Q3 2025), and $4.4 million (Q2 2025) per Business Quant data.